BioSpace News Archive

Drug Development

Cornerstone Pharmaceuticals, Inc. Presents Updated Phase I Data For CPI-613 At 2013 American Society of Hematology Annual Meeting

December 10, 2013
·
1 min read
Drug Development

Portola Pharmaceuticals, Inc. Announces New Phase 2 Results Confirming Immediate, Dose-Dependent And Well-Tolerated Reversal Of Anticoagulation Activity Of XARELTO® (Rivaroxaban) With Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Reversal

December 10, 2013
·
1 min read
Drug Development

FDA Grants Fast Track Designation To Navidea Biopharmaceuticals’ Lymphoseek® For Sentinel Lymph Node Detection In Patients With Head And Neck Cancer

December 10, 2013
·
1 min read
Business

ABC Laboratories, Inc. And University of Missouri Announce Internship Program

December 10, 2013
·
1 min read
Business

Southern Research Institute CEO Arthur J. Tipton Named A Fellow In The National Academy Of Inventors

December 10, 2013
·
1 min read
Drug Development

Emergent BioSolutions’ Otlertuzumab (TRU-016) Shows Positive Results In Combination With Rituximab In People With CLL

December 10, 2013
·
1 min read
Business

INVISTA To Collaborate With CPI To Develop Gas-Based, Bio-Derived Process Technology

December 10, 2013
·
1 min read
EyeTechCare Doubles The Number Of Health Care Facilities In France With The Eyeop1 Device

December 10, 2013
·
5 min read
Business

Kinematix Appoints Former Partners Healthcare Executive President Of U.S. Subsidiary

December 10, 2013
·
3 min read
BioCapital

Using Virtual Reality to Improve Seniors’ Stability: APMA

December 10, 2013
·
2 min read